Online Only Articles

Mass spectrometry-based identification of a naturally presented receptor tyrosine kinase-like orphan receptor 1-derived epitope recognized by CD8+ cytotoxic T cells

DKMS German Bone Marrow Donor Center, Clinical Trials Unit, Dresden, Germany;Department of Medicine I, University Hospital of Dresden, Germany
Department of Medicine I, University Hospital of Dresden, Germany;Center for Regenerative Therapies Dresden, TU Dresden, Germany
Department of Hematology and Oncology, University of Tübingen, Germany
Center for Regenerative Therapies Dresden, TU Dresden, Germany
Center for Regenerative Therapies Dresden, TU Dresden, Germany
Center for Regenerative Therapies Dresden, TU Dresden, Germany
Department of Hematology and Oncology, University of Tübingen, Germany;Department of Immunology, Institute for Cell Biology, University of Tübingen, Germany
Institute of Immunology, Medical Faculty Carl Gustav Carus, TU Dresden, Germany;National Center for Tumor Diseases, University Hospital Carl Gustav Carus, TU Dresden, Germany
Institute of Immunology, Medical Faculty Carl Gustav Carus, TU Dresden, Germany;National Center for Tumor Diseases, University Hospital Carl Gustav Carus, TU Dresden, Germany
Department of Medicine I, University Hospital of Dresden, Germany;Center for Regenerative Therapies Dresden, TU Dresden, Germany
Department of Medicine I, University Hospital of Dresden, Germany
Department of Medicine I, University Hospital of Dresden, Germany
German Red Cross Blood Donation Service North-East, Dresden, Germany
Department of Immunology, Institute for Cell Biology, University of Tübingen, Germany;German Cancer Consortium (DKTK), Tübingen, Germany;German Cancer Research Center (DKFZ), Heidelberg, Germany
Department of Immunology, Institute for Cell Biology, University of Tübingen, Germany;German Cancer Consortium (DKTK), Tübingen, Germany;German Cancer Research Center (DKFZ), Heidelberg, Germany
Center for Regenerative Therapies Dresden, TU Dresden, Germany
Center for Regenerative Therapies Dresden, TU Dresden, Germany;National Center for Tumor Diseases, University Hospital Carl Gustav Carus, TU Dresden, Germany;German Cancer Research Center (DKFZ), Heidelberg, Germany;German Cancer Consortium (DKTK), Dresden, Germany;Department of Radioimmunology, Institute of Radiopharmaceutical Cancer Research, Helmholtz Center Dresden-Rossendorf, Dresden, Germany
Städtisches Krankenhaus Kiel, Germany
Department of Medicine I, University Hospital of Dresden, Germany;Center for Regenerative Therapies Dresden, TU Dresden, Germany;National Center for Tumor Diseases, University Hospital Carl Gustav Carus, TU Dresden, Germany;German Cancer Research Center (DKFZ), Heidelberg, Germany;German Cancer Consortium (DKTK), Dresden, Germany
Department of Medicine I, University Hospital of Dresden, Germany;Center for Regenerative Therapies Dresden, TU Dresden, Germany;National Center for Tumor Diseases, University Hospital Carl Gustav Carus, TU Dresden, Germany;German Cancer Research Center (DKFZ), Heidelberg, Germany;German Cancer Consortium (DKTK), Dresden, Germany
DKMS German Bone Marrow Donor Center, Clinical Trials Unit, Dresden, Germany;Department of Medicine I, University Hospital of Dresden, Germany
Center for Regenerative Therapies Dresden, TU Dresden, Germany;Institute of Immunology, Medical Faculty Carl Gustav Carus, TU Dresden, Germany;National Center for Tumor Diseases, University Hospital Carl Gustav Carus, TU Dresden, Germany;German Cancer Research Center (DKFZ), Heidelberg, Germany;German Cancer Consortium (DKTK), Dresden, Germany
Vol. 102 No. 11 (2017): November, 2017 https://doi.org/10.3324/haematol.2017.167312